Comprehensive Early Cancer Risk Assessment Blood Test for Detection Focus on Common Cancers in Men and Women New Generation Gene Sequencing Technology with Accuracy Up to 99.9% Hong Kong's First Private Laboratory Equipped with NGS Instruments The Comprehensive Early Cancer Risk Assessment can simultaneously detect 270 cancer-related genes. It utilizes professional analysis based on genetic mutation data linked to common cancers in the Asian and Chinese populations, ensuring that the results are more accurate and relevant to the genetic makeup of these groups. The new OEC testing technology examines the entire genome, unlike traditional methods that only focus on popular mutation hotspots. This approach provides broader coverage of cancer-related gene mutations and is also capable of detecting common fusion genes associated with cancer, offering patients deeper and more comprehensive information.